|
|
|
|
| LEADER |
02492nmm a2200325 u 4500 |
| 001 |
EB000667262 |
| 003 |
EBX01000000000000000520344 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642599453
|
| 100 |
1 |
|
|a Senn, H.-J.
|e [editor]
|
| 245 |
0 |
0 |
|a Chemoprevention of Cancer
|h Elektronische Ressource
|b A Clinical Update
|c edited by H.-J. Senn, Alberto Costa, Craig Jordan
|
| 250 |
|
|
|a 1st ed. 1999
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1999, 1999
|
| 300 |
|
|
|a IX, 137 p. 1 illus. in color
|b online resource
|
| 505 |
0 |
|
|a I. Smoking, Genetics and Cancer -- Is There a Genetic Basis for Lung Cancer Susceptibility? -- Chemoprevention of Head and Neck and Lung (Pre)Cancer -- II. Targets and Markers for Cancer Prevention -- Rationale and Mechanisms of Cancer Chemoprevention -- Metabolic Targets of Cancer Chemoprevention: Interruption of Tumor Development by Inhibitors of Arachidonic Acid Metabolism -- III. Identification of Meaningful High Risk Groups for Cancer Chemoprevention -- Prognostic Implications of Cancer Susceptibility Genes: Any News? -- Identification of the Woman at Risk for Breast Cancer: Problem Solved? -- Development of a New Prevention Maintenance Therapy for Postmenopausal Women -- IV. Clinical Cancer Chemoprevention -- Chemoprevention of Human Cancer: A Reasonable Strategy? -- Chemoprevention of Colorectal Cancer
|
| 653 |
|
|
|a Cancer
|
| 653 |
|
|
|a Cancer Biology
|
| 653 |
|
|
|a Oncology
|
| 700 |
1 |
|
|a Costa, Alberto
|e [editor]
|
| 700 |
1 |
|
|a Jordan, Craig
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Recent Results in Cancer Research
|
| 028 |
5 |
0 |
|a 10.1007/978-3-642-59945-3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-59945-3?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 082 |
0 |
|
|a 571.978
|
| 520 |
|
|
|a This volume contains part of the papers given at the second annual conference of the newly founded International Society of Cancer Chemoprevention held in August 1997 in St. Gallen, Switzerland. Pharmacologic intervention in human carcinogenes is in its very infancy, and internationally coordinated efforts to fight the evolution of human cancers are only now taking shape. This is one of the first efforts to unite experts of all major groups and centers worldwide in the highly fascinating and thought-provoking field of chemoprevention of cancer, especially of the breast, colon and prostate
|